Sanbin Wang

883 total citations · 1 hit paper
31 papers, 259 citations indexed

About

Sanbin Wang is a scholar working on Oncology, Hematology and Immunology. According to data from OpenAlex, Sanbin Wang has authored 31 papers receiving a total of 259 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 16 papers in Hematology and 8 papers in Immunology. Recurrent topics in Sanbin Wang's work include CAR-T cell therapy research (12 papers), Hematopoietic Stem Cell Transplantation (12 papers) and Acute Lymphoblastic Leukemia research (5 papers). Sanbin Wang is often cited by papers focused on CAR-T cell therapy research (12 papers), Hematopoietic Stem Cell Transplantation (12 papers) and Acute Lymphoblastic Leukemia research (5 papers). Sanbin Wang collaborates with scholars based in China and United States. Sanbin Wang's co-authors include Lei Gao, Xi Zhang, Li Gao, Yao Liu, Yi Su, Peiyan Kong, Cheng Zhang, Jishi Wang, Tonghua Yang and Jiaping He and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Sanbin Wang

26 papers receiving 257 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Modified lentiviral globin gene therapy for pediatric β0/β0 transfusion-dependent β-thalassemia: A single-center, single-arm pilot trial

2024 41 citations Sanbin Wang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sanbin Wang China	9	137	102	74	52	49	31	259
Ira L. Kraft United States	9	130 0.9×	106 1.0×	77 1.0×	43 0.8×	59 1.2×	19	295
Irene García‐Cadenas Spain	7	133 1.0×	103 1.0×	64 0.9×	52 1.0×	27 0.6×	11	217
Kenneth Heym United States	10	135 1.0×	157 1.5×	102 1.4×	85 1.6×	40 0.8×	26	366
Kathleen Ruehle United States	8	212 1.5×	121 1.2×	78 1.1×	62 1.2×	27 0.6×	24	291
Sergi Querol Spain	11	88 0.6×	171 1.7×	90 1.2×	67 1.3×	112 2.3×	28	351
Álex Bataller United States	10	90 0.7×	208 2.0×	131 1.8×	46 0.9×	93 1.9×	51	319
Vipul Sheth United States	7	184 1.3×	99 1.0×	58 0.8×	84 1.6×	21 0.4×	22	273
Sibgha Gull Chaudhary United States	8	162 1.2×	100 1.0×	70 0.9×	81 1.6×	21 0.4×	38	302
Tiziana Moscato Italy	13	174 1.3×	269 2.6×	86 1.2×	64 1.2×	40 0.8×	33	339
Gabrielle T. Prince United States	9	114 0.8×	155 1.5×	82 1.1×	80 1.5×	46 0.9×	28	263

Countries citing papers authored by Sanbin Wang

Since Specialization

Citations

This map shows the geographic impact of Sanbin Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sanbin Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sanbin Wang more than expected).

Fields of papers citing papers by Sanbin Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sanbin Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sanbin Wang. The network helps show where Sanbin Wang may publish in the future.

Co-authorship network of co-authors of Sanbin Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Sanbin Wang. A scholar is included among the top collaborators of Sanbin Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sanbin Wang. Sanbin Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Shangjun, Li Liu, Yuhua Li, et al.. (2025). Novel CD19 Fast-CAR-T cells vs. CD19 conventional CAR-T cells for the treatment of relapsed/refractory CD19-positive B-cell acute lymphoblastic leukemia. Chinese Medical Journal. 138(19). 2491–2497. 1 indexed citations

Liu, Yang, Xu Yang, Bo Yang, et al.. (2025). Risk analysis of cardiovascular toxicity in patients with lymphoma treated with CD19 CAR T cells. Journal of Translational Medicine. 23(1). 8–8.

Li, Huiyuan, et al.. (2025). Venetoclax and azacitidine in combination with homoharringtonine, cytarabine, and aclarubicin for salvage therapy of relapsed/refractory T cell acute lymphoblastic leukemia. International Journal of Hematology. 121(4). 547–552.

Liu, Lin, et al.. (2024). A case of acute lung injury in a peripheral blood stem cell donor mobilized with pegylated recombinant human granulocyte colony-stimulating factor. International Journal of Hematology. 120(2). 262–266.

Xu, Zhengli, Jie Ji, Sanbin Wang, et al.. (2024). Clinical outcomes of three haploidentical transplantation protocols for hematologic malignancies based on data from the Chinese Bone Marrow Transplantation Registry Group. Haematologica. 110(3). 629–639. 3 indexed citations

Yang, Xu, Bo Yang, Juan Chen, et al.. (2024). Efficacy and safety of chimeric antigen receptor T cells targeting BCMA and GPRC5D in relapsed or refractory multiple myeloma. Frontiers in Immunology. 15. 1466443–1466443.

Gao, Mingyang, Sanbin Wang, Yanqi Zhang, et al.. (2024). Similar outcomes between HLA-haploid and matched sibling donor hematopoietic stem cell transplantation: a multicenter, retrospective study and severe aplastic anemia transplant-specific prognostic scoring system. Annals of Hematology. 104(1). 781–791.

Huang, Ruihao, Ting Chen, Sanbin Wang, et al.. (2023). Mesenchymal Stem Cells for Prophylaxis of Chronic Graft-vs-Host Disease After Haploidentical Hematopoietic Stem Cell Transplant. JAMA Oncology. 10(2). 220–220. 17 indexed citations

Li, Shiqi, Zhi Yang, Lin Liu, et al.. (2022). Autologous CD19-directed CAR T cells produced by novel PrimeCARmanufacture platform exhibit safety, efficacy, and long persistence profiles in relapsed/refractory B-lineage acute leukemia (r/r B-ALL).. Journal of Clinical Oncology. 40(16_suppl). 7008–7008. 1 indexed citations

10.

Qin, Wen, Li Gao, Qiong Li, et al.. (2021). High-dose Chemotherapy Combined with Autologous Hematopoietic Stem Cell Transplantation as Frontline Therapy for Intermediate/High-risk Diffuse Large B Cell Lymphoma. Current Medical Science. 41(3). 465–473. 5 indexed citations

11.

Li, Jiali, Sanbin Wang, Yicheng Zhang, et al.. (2020). Is It Better to Mobilize Hematopoietic Stem Cells With Pegfilgrastim in Healthy Donors During Allogeneic Hematopoietic Stem Cell Transplantation?. Frontiers in Oncology. 10. 1598–1598. 6 indexed citations

12.

Zhang, Hua, Lei Gao, Li Liu, et al.. (2019). A Bcma and CD19 Bispecific CAR-T for Relapsed and Refractory Multiple Myeloma. Blood. 134(Supplement_1). 3147–3147. 43 indexed citations

13.

Liu, Yao, Jun Rao, Jiali Li, et al.. (2019). Tandem autologous hematopoietic stem cell transplantation for treatment of adult T-cell lymphoblastic lymphoma: a multiple center prospective study in China. Haematologica. 106(1). 163–172. 10 indexed citations

14.

Zhang, Cheng, Jiaping He, Li Liu, et al.. (2019). CD19-Directed Fast CART Therapy for Relapsed/Refractory Acute Lymphoblastic Leukemia: From Bench to Bedside. Blood. 134(Supplement_1). 1340–1340. 13 indexed citations

15.

Wang, Sanbin, Jishi Wang, Li Liu, et al.. (2018). Optimal donor for severe aplastic anemia patient requiring allogeneic hematopoietic stem cell transplantation: A large-sample study from China. Scientific Reports. 8(1). 2479–2479. 18 indexed citations

16.

Min, Haiyan, Sanbin Wang, Yuqin Song, et al.. (2018). Remission of HIV-related naïve and high-risk Burkitt’s lymphoma treated by autologous stem cell transplantation plus cART. Stem Cell Research & Therapy. 9(1). 353–353. 2 indexed citations

17.

Gao, Li, Cheng Zhang, Lei Gao, et al.. (2015). Favorable outcome of haploidentical hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia: a multicenter study in Southwest China. Journal of Hematology & Oncology. 8(1). 90–90. 42 indexed citations

18.

Zhang, Xi, Yunlong Li, Yanqi Zhang, et al.. (2013). Etoposide in combination with low-dose CAG (cytarabine, aclarubicin, G-CSF) for the treatment of relapsed or refractory acute myeloid leukemia: A multicenter, randomized control trial in southwest China. Leukemia Research. 37(6). 657–664. 11 indexed citations

19.

Li, Jun, Li Zhang, Liang Zhou, et al.. (2012). Beneficial effects of non-matched allogeneic cord blood mononuclear cells upon patients with idiopathic osteoporosis. Journal of Translational Medicine. 10(1). 102–102. 8 indexed citations

20.

Peng, Lihui, et al.. (2010). Retrospective analysis of the effectiveness of a pediatric protocol BFM90 in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia. 19(6). 331–333. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact